PHARMACY

Teva promotes affordable healthcare campaign with online video release

BY Alaric DeArment

NEW YORK Teva Pharmaceuticals has made a series of online videos to promote the Year of Affordable Healthcare campaign it launched earlier this month that takes a cue from Apple’s successful “I’m a Mac” commercial spots.

The videos feature two characters, one representing branded drugs and another representing generic drugs, arguing about whether generic drugs offer the same benefits to consumers at a lower cost.

“We just need to let people know that we’re exactly the same, but I’m a lot more affordable,” “Generic Medication” says in the first video. “In fact, the federal government just said increased use of generics helps lower healthcare spending.”

“Well, that‘s totally obvious,” ‘Brand-Name’ says in response. “I don’t know why we have to make a commercial.”

The videos are available at www.yearofaffordablehealth.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Take Care clinics open in Arizona, Illinois

BY Antoinette Alexander

CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has announced the opening of two clinics in Chandler, Ariz., and Oak Lawn, Ill.

The new openings make 17 Take Care Clinics in the Phoenix market and 34 clinics in the Chicago market.

In total, the company operates 334 clinics in 35 markets throughout 19 states.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA approves new Sanofi-Aventis insulin pen

BY Alaric DeArment

BRIDGEWATER, N.J. The Food and Drug Administration has approved a new insulin pen from Sanofi-Aventis, the drug maker announced Thursday.

Apidra SoloSTAR (insulin glulisine [rDNA origin]) is a prefilled, disposable insulin pen containing the fast-acting insulin analog Apidra. Apidra is used to improve glycemic control in patients aged 4 and older with Type 1 and Type 2 diabetes. Its approval follows the 2007 approval and launch of Lantus SoloSTAR (insulin glargine [rDNA origin]).

 “People with diabetes have to contend with the challenges of carbohydrate counting, regular blood pressure monitoring and careful administration of their insulin,” Sanofi-Aventis U.S. VP metabolism marketing Angela Moskow stated. “Apidra SoloSTAR represents another innovation introduced by Sanofi-Aventis that offers patients a convenient option for administering their Apidra.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?